Obstetric crisis hemorrhage obstetric crisis hemorrhage
Conditions
Interventions
transfusion of a new methods of cryoprecipitate
Sponsors
Okazaki Hitoshi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Eligibility criteria for primary registration 1) Age: 20 years or older 2) Gender: Female only 3) Those who have received sufficient explanation for participating in this study, and who have obtained the consent of the document by their own free will 4) Those who have a risk of bleeding due to childbirth and obtain a blood transfusion consent form Eligibility criteria for secondary registration 1) Patients who meet the indication criteria of cryoprecipitate manual at the University of Tokyo Hospital Patients who meet at least one of the following conditions Visible bleeding and the clinical bleeding tendency is clear Rapid bleeding exceeding 150 ml / min Fibrinogen value is less than 150 mg / dL (PoCT test value is also acceptable)
Exclusion criteria
Exclusion criteria: Exclusion criteria for primary registration Patients with congenital coagulation factor deficiency such as congenital fibrinogen deficiency and hemophilia Exclusion criteria for secondary registration 1) Those who have performed primary registration and obtained consent to participate in the study, but do not have obstetrically critical bleeding, do not require blood transfusion, or do not meet the criteria for administering allogeneic cryo. 2) In addition, those who are judged by doctor to be inappropriate for participation in this research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference between measured and predicted fibrinogen values | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured bleeding volume, blood transfusion volume, postoperative hospital stay, Hb at discharge | — |
Contacts
Public ContactRui Terada
The University of Tokyo Hospital
Outcome results
None listed